Equities

Vincerx Pharma Inc

VINC:NAQ

Vincerx Pharma Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.75
  • Today's Change0.013 / 1.76%
  • Shares traded38.46k
  • 1 Year change-42.75%
  • Beta1.1550
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • VINC:NAQ price moved over +5.29% to 0.7995
  • VINC:NAQ price rises above 50-day moving average to 0.7481 at 10:56 BST
  • VINC:NAQ price falls below 50-day moving average to 0.7407 at 10:48 BST
  • VINC:NAQ trading volume exceeds daily average by +18.95%
  • VINC:NAQ price falls below 50-day moving average to 0.7411 at 13:55 BST

Key statistics

On Wednesday, Vincerx Pharma Inc (VINC:NAQ) closed at 0.75, 31.95% above the 52 week low of 0.5684 set on Jun 24, 2024.
52-week range
Today
0.5684Jun 24 20249.37Mar 11 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.7236
High0.7692
Low0.7236
Bid0.727
Offer0.74
Previous close0.737
Average volume294.01k
Shares outstanding29.53m
Free float24.18m
P/E (TTM)--
Market cap22.15m USD
EPS (TTM)-1.79
USD
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.